"Die Universitätsmedizin Halle ist die überregional anerkannte Expertin für schwierige, schwerste und seltene Erkrankungen und Verletzungen im südlichen Sachsen-Anhalt. Wir behandeln Patientinnen und Patienten aller Altersklassen nach neuesten wissenschaftlichen Erkenntnissen und profitieren dabei von der engen Verzahnung des Universitätsklinikums Halle (UKH) und der Medizinischen Fakultät der Martin-Luther-Universität Halle. Das UKH ist das erste Universitätsklinikum in Deutschland, in dem auch Pflege, Lehre und Forschung in die Krankenversorgung integriert sind."

During the past decade, Universitätsklinikum Halle conducted 113 clinical trials. In the 10-year time frame, 113 clinical trials started and 26 clinical trials were completed, i.e. on average, 23% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 19 clinical trials were completed. i.e. 42.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Halle" #1 sponsor was "Celgene" with 10 trials, followed by "Martin-Luther-Universität Halle-Wittenberg" with 7 trials sponsored, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored and "Incyte Corporation" with 5 trials sponsored. Other sponsors include 124 different institutions and companies that sponsored additional 94 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Halle" #1 collaborator was "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 3 trials as a collaborator, "German Research Foundation" with 3 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Charite University, Berlin, Germany" with 2 trials as a collaborator and "Deutsche Kinderkrebsstiftung" with 2 trials as a collaborator. Other collaborators include 93 different institutions and companies that were collaborators in the rest 97 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Halle" are "Primary Myelofibrosis" (9 trials), "Ulcerative Colitis" (8 trials), "Myelofibrosis" (7 trials), "Acute Myeloid Leukemia" (6 trials) and "AML" (5 trials). Many other conditions were trialed in "Universitätsklinikum Halle" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Halle" are "Drug" (115 trials), "Other" (21 trials), "Biological" (19 trials), "Device" (18 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "radiation therapy" (9 trials), "cyclophosphamide" (7 trials), "doxorubicin hydrochloride" (7 trials) and "vincristine sulfate" (7 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Halle" are 152 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Universitätsklinikum Halle". undefined are not yet recruiting, 43 are recruiting, 32 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Universitätsklinikum Halle, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Halle, 7 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".